Kisspeptin 10mg

Kisspeptin peptides — also referenced in scientific literature as metastin or KISS1-derived ligands — are endogenous neuropeptides extensively studied in vertebrate neuroendocrinology and cellular signaling research. Kisspeptin-10 (Kp-10) represents a short C-terminal active fragment frequently utilized in experimental models to examine KISS1 receptor (KISS1R/GPR54) activation, downstream signal transduction pathway dynamics, and gene-regulatory outcomes across central and peripheral tissue research systems.

Within preclinical research literature, kisspeptin signaling is commonly explored for its involvement in hypothalamic GnRH neuron activation pathway dynamics, pituitary gonadotropin release mechanism research, metabolic signaling integration, vascular biology endpoints, and tumor cell migration and adhesion behavior investigation in both cell-based assay systems and controlled animal research models.

Biochemical Characteristics

• Peptide Sequence: YNWNSFGLRF
• Molecular Formula: C₆₃H₈₃N₁₇O₁₄
• Molecular Weight: 1,302.4 g/mol
• PubChem CID: 25240297
• Alternate Names: KISS-1, Protein KISS-1, Metastin, Kisspeptin-10

Research Applications & Mechanistic Context

Kisspeptin-10 is widely applied in laboratory research as a KISS1R agonist probe, enabling investigators to map receptor-driven signaling events under controlled experimental conditions. Activation of KISS1R in experimental systems is associated with:

• Intracellular calcium mobilization pathway dynamics
• Kinase signaling cascade engagement and downstream activity
• Transcriptional program modulation under defined experimental conditions

In neuroendocrine-focused research models, kisspeptin signaling serves as a key experimental tool for examining GnRH neuron excitability, pulsatile gonadotropin secretion dynamics, and regulatory feedback mechanisms within the hypothalamic–pituitary–gonadal (HPG) axis under controlled nonclinical laboratory conditions.

Preclinical Research Contexts

GnRH Neuron Activation & Gonadotropin Regulation Research
Experimental studies using kisspeptin ligands have characterized KISS1R-dependent activation of GnRH neurons and associated downstream changes in gonadotropin secretion profiles in controlled research settings. These models are commonly utilized to assess pulse frequency dynamics, receptor responsiveness parameters, and axis-level signaling dynamics under defined stimulation paradigms.

Metabolic & Energy Balance Interface Research
Kisspeptin neurons are studied as integrative signaling nodes linking metabolic status with neuroendocrine output in controlled preclinical research systems. Preclinical genetic and receptor-expression studies have reported KISS1R localization in adipose and peripheral tissues, with receptor-deficient animal models utilized to evaluate adiposity-related phenotypes, energy expenditure endpoints, and metabolic signaling pathway dynamics. This work supports ongoing investigation into kisspeptin pathway intersections with systemic metabolic regulation mechanisms.

Oncology & Cell Migration Endpoint Research
In oncology-focused laboratory research, KISS1/kisspeptin signaling has been examined for its association with tumor cell motility, adhesion dynamics, and metastatic behavior endpoints. Experimental findings across multiple tumor research models suggest kisspeptin-related modulation of migration and invasion-associated process endpoints, with emphasis on context-dependent signaling dynamics and heterogeneity across cell lines and model systems.

Additional studies have explored potential interactions between kisspeptin signaling, circadian regulation pathway dynamics, and melatonin-associated pathway activity in mouse models evaluating tumor growth parameter endpoints. These observations support further investigation into endocrine–circadian cross-talk within the tumor microenvironment research context.

Learning, Memory & Behavioral Research Paradigms
Select preclinical studies have evaluated kisspeptin-related peptides in rodent behavioral assay systems examining spatial learning, navigation endpoint measurement, and cognitive flexibility parameters under controlled experimental conditions. Such work contributes to broader mechanistic hypotheses regarding peptide-mediated neuromodulation and neural circuit-level function in controlled research settings.

Neural Circuit & Affective Processing Research
Research has examined kisspeptin-associated modulation of limbic and reward-related neural circuit dynamics, using experimental brain activity readout methodologies to explore how neuroendocrine peptides influence motivational and affective processing pathway endpoints in controlled nonclinical research models.

Renal & Cardiovascular Biology Research
Expression of kisspeptin and KISS1R has been reported in renal tissue samples, with receptor knockout research models utilized to investigate developmental and functional renal endpoint parameters. In cardiovascular research contexts, kisspeptin signaling has been evaluated for tissue-specific effects within vascular systems, including vasoreactivity endpoint studies and vascular signaling mechanism investigation, with emphasis on receptor distribution patterns and context-dependent response dynamics.

Preclinical Research Summary

Published preclinical literature documents Kisspeptin-10 investigation across the following primary research contexts:

• KISS1R/GPR54 receptor activation and downstream signal transduction pathway dynamics
• Hypothalamic GnRH neuron excitability and gonadotropin secretion pattern research
• HPG axis regulatory feedback mechanism investigation under defined experimental conditions
• Metabolic signaling integration and energy balance interface pathway research
• Tumor cell motility, adhesion, and metastatic behavior endpoint modeling
• Limbic and reward-related neural circuit activity investigation
• Renal developmental and functional endpoint parameter assessment
• Vascular signaling mechanism and vasoreactivity endpoint research

All findings are derived exclusively from controlled preclinical research systems and do not represent clinical outcomes of any kind.

Form & Analytical Characterization

Kisspeptin-10 is supplied as a synthetic peptide intended for controlled laboratory research workflows. Peptide identity is documented through sequence verification and registry identifiers. Researchers may apply internal qualification procedures including:

• Chromatographic Purity Analysis (HPLC) — purity profiling and lot consistency verification
• Mass-Based Identity Confirmation (MS) — molecular mass verification consistent with standard peptide characterization practices

Purity & Quality

• ≥99% Purity — HPLC Verified
• Independently tested by accredited third-party laboratory
• Certificate of Analysis (CoA) available for every batch

Research Use Only (RUO) Notice

All products are furnished strictly for in-vitro laboratory research use only. "In-vitro" refers to studies conducted outside of a living organism in controlled laboratory conditions. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.

Here's your Kisspeptin-10 storage page rewrite, ready to paste:

Kisspeptin-10 — Storage & Stability Guidelines

Page/Section Title:
Kisspeptin-10 — Storage, Stability & Lyophilization Information

Short Introduction:
All P1 Peptides Kisspeptin-10 research compounds are manufactured using a lyophilization (freeze-drying) process to ensure maximum structural integrity and compound stability during transit and storage. The following guidelines are provided to support proper laboratory handling of this research-grade peptide material.

Manufacturing Process: Lyophilization

All Kisspeptin-10 research compounds supplied by P1 Peptides are produced using lyophilization — also referred to as cryodesiccation — a controlled dehydration process widely employed in the manufacture of research-grade synthetic peptide materials.

During this process, peptides are first frozen and then subjected to reduced pressure conditions, allowing water to transition directly from the solid phase to vapor — bypassing the liquid state entirely. This yields a dry, porous white crystalline material — commonly referred to as a lyophilized peptide — that preserves full structural integrity of the compound throughout the handling and storage period.

In its lyophilized form, Kisspeptin-10 research compounds remain stable during shipment for approximately three to four months under appropriate conditions prior to reconstitution.

Reconstitution

When research protocols require reconstitution, Kisspeptin-10 is typically prepared using bacteriostatic water under controlled laboratory conditions. Once reconstituted, the peptide solution should be stored under refrigerated conditions to maintain compound stability and structural integrity. When properly reconstituted and kept cold, peptide solutions typically retain stability for up to 30 days.

All reconstitution procedures should be carried out in accordance with standard laboratory protocols applicable to synthetic peptide research materials.

Recommended Storage Guidelines

The following storage parameters are recommended to maintain compound integrity throughout the research lifecycle:

Short-Term Storage — Unopened Lyophilized Vials

• Upon Receipt — Protect from heat and direct light exposure immediately upon receipt
• Short-Term Use (several days to a few months) — Refrigeration below 4°C (39°F) is generally sufficient to maintain compound integrity
• Room Temperature Storage — Lyophilized Kisspeptin-10 demonstrates stability at ambient temperatures for several weeks, making room-temperature storage acceptable for near-term laboratory research use prior to reconstitution

Long-Term Storage — Unopened Lyophilized Vials

• Extended Storage (several months to years) — Freezing is strongly recommended for long-term compound preservation
• Optimal Long-Term Preservation — Storage at ultra-low temperatures of −80°C (−112°F) provides optimal long-term stability and helps maintain peptide structural integrity over extended storage periods

Post-Reconstitution Storage

• Store reconstituted solutions under refrigeration below 4°C (39°F), away from direct light and heat sources
• Do not freeze reconstituted solutions
• Discard any unused reconstituted material after 30 days or upon observation of cloudiness, discoloration, or particulate matter

Additional Laboratory Guidance

For specific storage requirements applicable to this research compound, researchers should consult the Certificate of Analysis (CoA) provided with each batch, as well as applicable peer-reviewed literature and institutional laboratory protocols governing synthetic peptide handling and storage procedures.

Research Use Only (RUO) Notice

All products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.